Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $112 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Tenet Healthcare (NYSE:THC) and maintained a price target of $112.
July 02, 2024 | 3:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Tenet Healthcare (NYSE:THC) and maintained a price target of $112.
The reiteration of an Overweight rating and a maintained price target of $112 by a reputable analyst is likely to positively impact Tenet Healthcare's stock price in the short term. This indicates continued confidence in the company's performance and potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100